严重钙化股腘动脉硬化性闭塞症血管腔内治疗的现状及展望

doi:10.16139/j.1007-9610.2019.04.005

摘要/Abstract

中图分类号:

R654.3

王预立, 叶猛. 严重钙化股腘动脉硬化性闭塞症血管腔内治疗的现状及展望[J]. 外科理论与实践, 2019, 24(04): 301-303.

[1] Claesson K, Kölbel T, Acosta S.Role of endovascular intervention in patients with diabetic foot ulcer and concomitant peripheral arterial disease[J]. Int Ang,2011,30(4):349-358.
[2] Norgren L. Hiatt WR, Dormandy JA, et al.Inter-Society Consensus for the Management of Peripheral Arterial Di-sease (TASC Ⅱ)[J]. J Vasc Surg,2007,45(Suppl S):S5-S67.
[3] Fanelli F, Cannavale A, Gazzetti M, et al.Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease[J]. J Vasc Interv Radiol,2014, 37(4):898-907.
[4] Mckinsey JF, Zeller T, Rocha-Singh KJ, et al.Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE Study[J]. JACC Cardiovasc Interv,2014,7(8):923-933.
[5] Shammas NW, Coiner D, Shammas GA, et al.Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial[J]. J Vasc Interv Radiol,2011,22(9):1223-1228.
[6] Zeller T, Langhoff R, Rocha-Singh KJ, et al.Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency[J]. Circ Cardovasc Inte,2017,10(9):e004848.
[7] Adams GL, Das T, Lee MS, et al.Subanalysis of the CONFIRM registries: Acute procedural outcomes in claudicant and critical limb ischemia patients with varying levels of calcification treated for peripheral arterial di-sease with orbital atherectomy[J]. J Invasive Cardiol,2015, 27(11):516-520.
[8] Dattilo R, Himmelstein SI, Cuff RF.The COMPLIANCE 360° Trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease[J]. J Invasive Cardiol,2014,26(8):355-360.
[9] Dippel EJ, Makam P, Kovach R, et al.Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis)[J]. JACC Cardiovasc Interv,2015,8(1 Pt A):92-101.
[10] Otsuka F, Nakano M, Sakakura K, et al.Unique demands of the femoral anatomy and pathology and the need for unique interventions[J]. J Cardivasc Surg,2013, 54(2):191-210.
[11] 蒋俊豪, 陈斌, 董智慧, 等. 腘动脉的解剖学特点与腘动脉硬化闭塞的腔内治疗[J]. 中华普通外科杂志,2014, 29(6):452-454.
[12] Goltz JP, Ritter CO, Kellersmann R.Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force[J]. J Endovasc Ther,2012,19(3):450-456.
[13] Werner M, Paetzold A, Banning-Eichenseer U, et al.Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 re-gistry[J]. Euro Intervention,2014,10(7):861-868.
[14] Dake MD, Ansel GM, Jaff MR, et al.Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease twelve-month zilver PTX randomized study results[J]. Circ Cardovasc Inte,2011,4(5):495-504.
[15] Mcquade K, Gable D, Hohman S, et al.Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease[J]. J Vasc Surg,2009,49(1):109-115.
[16] Gandini R, Giudice CD.Local ultrasound to enhance paclitaxel delivery after femoral-popliteal treatment in critical limb ischemia: The PACUS trial[J]. JACC Cardiovas Inte,2016,9(20):2147-2153.
[17] Brodmann M, Werner M, Brinton TJ, et al.Safety and performance of lithoplasty for treatment of calcified peripheral artery lesions[J]. J Am Coll Cardiol,2017,70(7):908-910.
[18] Brodmann M, Werner M, Holden A, et al.Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD Ⅱ[J]. Catheter Cardiovas Inte,2019,93(2):335-342.
[19] Gasper WJ, Jimenez CA, Walker J, et al.Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation[J]. Circ Cardovasc Inte,2013,6(6):701-709.
[20] Owens CD, Gasper WJ, Walker JP, et al.Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization[J]. J Vasc Surg,2014,59(4):1016-1024.

严重钙化股腘动脉硬化性闭塞症血管腔内治疗的现状及展望

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈忠, 寇镭,. 复杂主髂动脉闭塞症的治疗选择[J]. 外科理论与实践, 2015, 20(04): 289-293.
[2]	叶开创, 殷敏毅, 陆信武, 李维敏, 黄英, 黄新天, 陆民, 刘晓兵, 赵海光, 施慧华, 刘光, 蒋米尔,. 支架成形术治疗髂动脉慢性闭塞症的中长期疗效分析[J]. 外科理论与实践, 2013, 18(05): 425-428.
[3]	陈斌, 符伟国, 史振宇, 竺挺, 董智慧,. 脾动脉瘤的传统手术和腔内治疗的比较[J]. 外科理论与实践, 2011, 16(05): 488-490.
[4]	蒋米尔, 黄英,. 下肢动脉粥样硬化闭塞症治疗的过去、现在和未来[J]. 外科理论与实践, 2009, 14(03): 249-256.
[5]	陆民,. 人工血管在膝下动脉重建术中的应用[J]. 外科理论与实践, 2009, 14(03): 257-259.
[6]	王豪夫, 刘军军, 王曰伟, 李君, 赵宗刚, 戚森, 田明夏,. 股-腘动脉旁路术应用袖状接头碳涂层人工血管的临床分析[J]. 外科理论与实践, 2009, 14(03): 339-340.
[7]	张皓. 血管内皮生长因子基因治疗下肢动脉闭塞症[J]. 外科理论与实践, 2004, 9(03): 252-254.
[8]	田路,梅劲桦,张纪蔚,张柏根. 下肢多平面动脉闭塞症的术式探讨[J]. 外科理论与实践, 2004, 9(01): 43-45.
[9]	陆信武,黄英,李维敏,朱雯霞,刘晓兵,殷敏毅,黄新天,陆民,张培华,蒋米尔. 下肢动脉硬化闭塞症的外科治疗[J]. 外科理论与实践, 2004, 9(01): 46-49.
[10]	张柏根. 下肢动脉粥样硬化闭塞症的临床分型与旁路转流术[J]. 外科理论与实践, 2004, 9(01): 3-5.
[11]	吕伟明,李晓曦,王深明,林勇杰. 颈内动脉硬化闭塞症手术三种术式的适应证和操作要点[J]. 外科理论与实践, 2001, 6(05): 350-352.
[12]	王玉琦,曲乐丰. 下肢动脉硬化闭塞症外科治疗的评估[J]. 外科理论与实践, 2001, 6(05): 269-272.
[13]	张纪蔚,张柏根,张皓,黄晓钟. 下肢多平面动脉闭塞症的动脉重建术[J]. 外科理论与实践, 1999, 4(02): 181-5.
[14]	梁卫,张纪蔚,张柏根. 放射性核素和踝/肱指数随访评估下肢ASO术后效果[J]. 外科理论与实践, 1998, 3(04): 119-5.
[15]	蒋米尔,陆民,黄新天,朱雯霞,何廷政,黄英,李维敏,张培华. 血管腔内支架成形术治疗髂动脉硬化闭塞症[J]. 外科理论与实践, 1998, 3(04): 124-5.